Skip to content
Pharma Observatory a Scientist.com platform

Organization (Other)

Truway Health, Inc.

ClinicalTrials.gov lists Truway Health, Inc. as lead sponsor of 16 trials. It has 27 active development programs.

Other
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Disease areas Disease areas 48 Trials by start year as sponsor or collaborator Trials by start year as sponsor or collaborator 2 Active development programs Active development programs 27 Journals published in Journals published in 27 Latest dated events Latest dated events 16 Biomarker capability evidence Biomarker capability evidence 4 Disease areas Disease areas 48 Trials by start year as sponsor or collaborator Trials by start year as sponsor or collaborator 2 Active development programs Active development programs 27 Journals published in Journals published in 27 Latest dated events Latest dated events 16 Biomarker capability evidence Biomarker capability evidence 4

Rows recorded per section (log scale)

18 sections measured, none recorded

This page covers Truway Health, Inc.: 16 lead-sponsored trials and 0 legal-entity registrations.

Get the Truway Health, Inc. report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Disease areas (48)

Shown in this order: most trials first.

Disease areas
Disease area Trials
Atherosclerosis 2
Disease 2
Disease Progression 2
Hypertension 2
Peripheral Arterial Disease 2

Showing 5 of 48 disease areas.

Start your 14-day trial Email me all 48 disease areas as a PDF

Trials by start year as sponsor or collaborator (2)

Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials by start year as sponsor or collaborator
Year Trials started
2026 (partial year) 11
2025 5

No forecast is made for this organization: it averages 3.2 trial starts a year over the five years to September, under the 5 a year the method needs.

Prediction, not a registry value: median of 26 months from start to primary completion across 6 trials still running at the 2026-10-09 snapshot. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.

Active development programs (27)

Shown in this order: max phase, then active trials.

Active development programs
Drug Disease area Max phase Trials
Low Dose Naltrexone Multiple Sclerosis Phase 1/2 1
Low Dose Naltrexone Lupus Erythematosus, Systemic Phase 1/2 1
Low Dose Naltrexone Arthritis, Rheumatoid Phase 1/2 1
Standard Oral Hypoglycemic Agent Hyperlipidemias Early 1 1
Standard Oral Hypoglycemic Agent Insulin Resistance Early 1 1

Showing 5 of 27 active programs.

Start your 14-day trial Email me all 27 active programs as a PDF

Journals published in (27)

Shown in this order: most published in first.

Journals published in
Journal Publications
Annals of emergency medicine 2
American journal of respiratory and critical care medicine 1
Annual review of clinical psychology 1
Annual review of medicine 1
BioMed research international 1

Showing 5 of 27 journals.

Start your 14-day trial Email me all 27 journals as a PDF

Latest dated events (16)

Shown in this order: newest first.

Latest dated events
Date Event Source
2026-09-15 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-09-02 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-09-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-09-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-09-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))

Showing 5 of 16 events.

Start your 14-day trial Email me all 16 events as a PDF

Biomarker capability evidence (4)

Shown in this order: tier desc, then gene symbol.

Biomarker capability evidence
Gene Role Evidence
MPZL2 Trial sponsor Named in trial inclusion criteria
SGCE Trial sponsor Named in trial inclusion criteria
MPZL2 Trial sponsor Mentioned in trial text
SGCE Trial sponsor Mentioned in trial text

Not on this page

Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, approved assets, sponsor delivery record, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, organization relationships, clia clinical laboratory certificates, and biomarkers this organization publishes on.